WINSTON MEDICAL SUPPLY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.5 TWD | -4.40% |
|
+2.76% | +32.89% |
| Sales 2022 | 607M 18.66M | Sales 2023 | 709M 21.81M | Capitalization | 1.81B 55.63M |
|---|---|---|---|---|---|
| Net income 2022 | 111M 3.41M | Net income 2023 | 159M 4.89M | EV / Sales 2022 | 1.64 x |
| Net cash position 2022 | 141M 4.32M | Net cash position 2023 | 235M 7.24M | EV / Sales 2023 | 2.22 x |
| P/E ratio 2022 |
10.3
x | P/E ratio 2023 |
11.4
x | Employees | 180 |
| Yield 2022 |
8.09% | Yield 2023 |
6.72% | Free-Float | 34.99% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.40% | ||
| 1 week | +2.76% | ||
| Current month | +2.76% | ||
| 1 month | +0.77% | ||
| 3 months | +29.85% | ||
| 6 months | +44.52% | ||
| Current year | +32.89% |
1 week
123.00
139.50
1 month
119.00139.50
Current year
96.90145.00
1 year
75.60145.00
3 years
51.90145.00
5 years
36.20145.00
10 years
36.20145.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Cheng Wang
CEO | Chief Executive Officer | - | 10-06-30 |
Hsin Wen Chang
DFI | Director of Finance/CFO | - | 20-03-12 |
Chin Hung Tsai
IRO | Public Communications Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stanley Chang
CHM | Chairman | 81 | 14-02-06 |
Yao Hsien Wang
BRD | Director/Board Member | - | 21-01-17 |
Ya Ling Chiang
BRD | Director/Board Member | - | 20-06-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 130.5 | -4.40% | 161,599 |
| 24-04-12 | 136.5 | +0.74% | 215,261 |
| 24-04-11 | 135.5 | +8.40% | 336,613 |
| 24-04-10 | 125 | -0.40% | 56,570 |
| 24-04-09 | 125.5 | -1.18% | 101,337 |
End-of-day quote Taipei Exchange, April 14, 2024
More quotes
Winston Medical Supply Co Ltd is a Taiwan-based company mainly engaged in the manufacturing and sales of western medicines, medical beauty products and food, as well as import and export transactions, agency for domestic and foreign manufacturers, and bidding. The Company's main business is the manufacturing, research and development and sales of scientifically-known drugs and medical aesthetics products. The Company's main products are eye medicine, oral medicine, hormone medicine, topical medicine, health food, cosmetics and others. Products are sold at home and abroad.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +32.89% | 77.8M | |
| +21.87% | 44.2B | |
| +18.85% | 22.64B | |
| +10.53% | 13.49B | |
| +4.03% | 12.68B | |
| +36.73% | 11.58B | |
| -7.05% | 7.33B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.00% | 5.17B |
- Stock Market
- Equities
- 6817 Stock
